FDA approves personalized cellular therapy for advanced leukemia developed by University of Pennsylvania and Children’s Hospital of Philadelphia
Credit: Penn Medicine PHILADELPHIA – In a landmark decision for the field of cancer immunotherapy, the U.S. Food and Drug Administration (FDA) today approved a...













